About Redcliffe Genetics
Redcliffe Genetics is a company based in Noida (India) founded in 2017 by Ashish Dubey, Dheeraj Jain, and Aditya Kandoi. Redcliffe Genetics has raised $63.21 million across 5 funding rounds from investors including LeapFrog Investments, Schroders and HealthQuad. The company has 2,104 employees as of May 31, 2025. Redcliffe Genetics operates in a competitive market with competitors including Novogene Corporation, Rejuvenate Bio, Source BioScience, Beikang Medical and deCODE Genetics, among others.
- Headquarter Noida, India
- Employees 2104 as on 31 May, 2025
- Founders Ashish Dubey, Dheeraj Jain, Aditya Kandoi
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$210.35 K (USD)-78as on Mar 31, 2024
-
Net Profit
-$1.31 M (USD)-14as on Mar 31, 2024
-
EBITDA
-$1.31 M (USD)-16as on Mar 31, 2024
-
Total Equity Funding
$63.21 M (USD)
in 5 rounds
-
Latest Funding Round
$61 M (USD), Series B
May 06, 2022
-
Investors
LeapFrog Investments
& 34 more
-
Employee Count
2104
as on May 31, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Redcliffe Genetics
Redcliffe Genetics has successfully raised a total of $63.21M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $61 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Redcliffe Genetics
Redcliffe Genetics has secured backing from 35 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include LeapFrog Investments, Schroders and HealthQuad.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity fund focused on banking, finance, healthcare, and multiple sectors
|
Locked | Locked | Locked | |
|
Healthcare investment fund focused on innovation and social impact in India.
|
Locked | Locked | Locked | |
|
Seed-stage tech-focused VCl firm investing primarily in the US
|
Locked | Locked | Locked |
Investor details for Redcliffe Genetics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Redcliffe Genetics
Investment portfolio details for Redcliffe Genetics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Redcliffe Genetics
Detailed financials for Redcliffe Genetics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Redcliffe Genetics Comparisons
Peer comparison for Redcliffe Genetics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Redcliffe Genetics
Redcliffe Genetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novogene Corporation, Rejuvenate Bio, Source BioScience, Beikang Medical and deCODE Genetics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
Multiple genomic services are provided for analysis and diagnostics.
|
|
| Locked | Locked | Locked |
NGS-based diagnostic solutions for neonatal screening are developed.
|
|
| Locked | Locked | Locked |
Bioinformatics platform for genetic disease analysis is provided.
|
|
| Locked | Locked | Locked |
Next-generation sequencing and genomics services are provided globally.
|
Detailed competitors of Redcliffe Genetics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Redcliffe Genetics
Complete news archive for Redcliffe Genetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Redcliffe Genetics
Redcliffe Genetics was founded in 2017.
Redcliffe Genetics is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.
Redcliffe Genetics is a funded company, having raised a total of $63.21M across 5 funding rounds to date.
As of May 31, 2025, the latest employee count at Redcliffe Genetics is 2,104.
Annual revenue of Redcliffe Genetics is $210.35K as on Mar 31, 2024.
Redcliffe Genetics was established in 2017 in Noida, India, within the genetics and diagnostics sector. Products and services are delivered to research institutions, healthcare providers, and industry collaborators. High-throughput platforms, including MGI DNB-Seq and nanostring technologies, are integrated for sequencing applications. Offerings include whole genome sequencing, exome sequencing, amplicon sequencing, and molecular diagnostics targeting cytogenetics, rare genetic disorders, and infertility.
Redcliffe Genetics's top competitors include Novogene Corporation, Source BioScience and Genewiz.
Redcliffe Genetics has 35 investors. Key investors include LeapFrog Investments, Schroders, HealthQuad, Alkemi Partners, and Jaipuria Group.
The valuation of Redcliffe Genetics is $1.82M as of Feb 2021.